C.R. Bard, Inc. (BCR) Tops Q4 EPS by 2c

C.R. Bard, Inc. (NYSE: BCR) reported Q4 EPS of $1.70, $0.02 better than the analyst estimate of $1.68. Revenue for the quarter came in at $750 million versus the consensus estimate of $748.59 million.

For earnings history and earnings-related data on C.R. Bard, Inc. (BCR) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Calidi Biotherapeutics (CLDI) Reports Q2 Loss of $2.94
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M